We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$87.5B
AUM Growth
+$6.24B
Cap. Flow
-$2.46B
Cap. Flow %
-2.82%
Top 10 Hldgs %
10.13%
Holding
4,337
New
572
Increased
1,477
Reduced
1,498
Closed
412

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$546M
2
AMZN icon
Amazon
AMZN
+$515M
3
TSLA icon
Tesla
TSLA
+$389M
4
NFLX icon
Netflix
NFLX
+$322M
5
ADBE icon
Adobe
ADBE
+$305M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$836M
2
CELG
Celgene Corp
CELG
+$460M
3
NVDA icon
NVIDIA
NVDA
+$429M
4
COP icon
ConocoPhillips
COP
+$311M
5
BIIB icon
Biogen
BIIB
+$301M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Healthcare 9.92%
4 Financials 7.86%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXU icon
3851
LSB Industries
LXU
$881M
$50K ﹤0.01%
+15,500
New +$52.3K
CVIA
3852
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$50K ﹤0.01%
24,316
+9,581
+65% +$15.5K
SNCR
3853
DELISTED
Synchronoss Technologies
SNCR
$48K ﹤0.01%
+1,123
New +$49.9K
JMEI
3854
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$44K ﹤0.01%
+2,167
New +$42.9K
DSKE
3855
DELISTED
Daseke, Inc. Common Stock
DSKE
$41K ﹤0.01%
13,111
+1,703
+15% +$4.99K
PDSB icon
3856
PDS Biotechnology
PDSB
$38.1M
$35K ﹤0.01%
13,281
-397
-3% -$1.13K
VTVT icon
3857
vTv Therapeutics
VTVT
$121M
$35K ﹤0.01%
517
-223
-30% -$13.5K
FBRX icon
3858
Forte Biosciences
FBRX
$1.12B
$34K ﹤0.01%
169
-137
-45% -$31K
TKKSW
3859
DELISTED
TKK Symphony Acquisition Corporation Warrant
TKKSW
$34K ﹤0.01%
574,288
MDR
3860
PUT
DELISTED
McDermott International
MDR
$34K ﹤0.01%
50,000
ECOR icon
3861
electroCore
ECOR
$51.4M
$32K ﹤0.01%
1,358
+54
+4% +$1.38K
VBIV
3862
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$30K ﹤0.01%
723
-1,442
-67% -$31.6K
VUZI icon
3863
Vuzix
VUZI
$190M
$27K ﹤0.01%
+13,460
New +$30.5K
AQMS icon
3864
Aqua Metals
AQMS
$9.63M
$24K ﹤0.01%
159
+10
+7% +$2.6K
RIOT icon
3865
Riot Platforms
RIOT
$8.52B
$23K ﹤0.01%
+20,449
New +$30.6K
VIVS
3866
VivoSim Labs
VIVS
$1.46M
$22K ﹤0.01%
259
-130
-33% -$12.2K
WATT icon
3867
Energous
WATT
$80.3M
$21K ﹤0.01%
+19
New +$28.2K
TALO.WS
3868
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$21K ﹤0.01%
12,800
AVEO
3869
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$20K ﹤0.01%
+3,128
New +$23K
ICD
3870
DELISTED
Independence Contract Drilling, Inc.
ICD
$18K ﹤0.01%
878
-250
-22% -$4.46K
NGD
3871
DELISTED
New Gold Inc
NGD
$15K ﹤0.01%
16,600
-20,092
-55% -$18.2K
UNT
3872
DELISTED
UNIT Corporation
UNT
$15K ﹤0.01%
21,828
-218,251
-91% -$348K
SMRT
3873
DELISTED
Stein Mart Inc
SMRT
$11K ﹤0.01%
16,600
-64,854
-80% -$49.5K
ADXS
3874
DELISTED
Advaxis Inc
ADXS
$10K ﹤0.01%
11,657
-37,300
-76% -$17K
MLNT
3875
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$8K ﹤0.01%
+14,335
New +$34.8K

Similar funds

D.E. Shaw & Co's Q4 2019 Portfolio in Review

As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
  • D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
  • D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
  • D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
  • D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
  • D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.